Theodore J. Witek, Theravance's Sr. VP & Chief Scientific Off., recently disposed of 26,590 shares of the company. The disposals took place at prices ranging from $16.44 to $16.60 per share, on dates ranging from February 20 to February 21, 2018. Witek still owns 187,573 shares of the company. Witek operates out of Brisbane, CA. Some additional info was provided as follows:
The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.
This sale was effected for tax planning purposes.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.58 to $16.64, inclusive. The Reporting Person
undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
Includes 363 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on November 15, 2017.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Theravance makes a similar move, sign up!
Other recent filings from the company include the following:
Theravance's Chief Accounting Officer just declared owning 24,104 shares of Theravance - Aug. 13, 2018
Departure of Directors or Certain - Aug. 8, 2018